메뉴 건너뛰기




Volumn 14, Issue 2, 2012, Pages 226-231

Quality of life issues in men undergoing androgen deprivation therapy: A review

Author keywords

androgen deprivation therapy; men; prostate cancer; quality of life

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; TESTOSTERONE;

EID: 84858063202     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.108     Document Type: Review
Times cited : (55)

References (96)
  • 1
    • 0015370976 scopus 로고
    • Studies on prostatic cancer I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate
    • Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972; 22: 232-40.
    • (1972) CA Cancer J Clin , Issue.22 , pp. 232-240
    • Huggins, C.1    Hodges, C.V.2
  • 3
    • 77955279420 scopus 로고    scopus 로고
    • Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
    • Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11: 725-32.
    • (2010) Lancet Oncol , vol.11 , pp. 725-732
    • Hugosson, J.1    Carlsson, S.2    Aus, G.3    Bergdahl, S.4    Khatami, A.5
  • 6
    • 18644367900 scopus 로고    scopus 로고
    • Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer
    • discussion, 11-2
    • Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP et al. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology 60: 2002; 7-11; discussion 11-2.
    • (2002) Urology , vol.60 , pp. 7-11
    • Meng, M.V.1    Grossfeld, G.D.2    Sadetsky, N.3    Mehta, S.S.4    Lubeck, D.P.5
  • 8
    • 70349395222 scopus 로고    scopus 로고
    • Anti-androgens and androgen-depleting therapies in prostate cancer: New agents for an established target
    • Chen Y, Clegg NJ, Scher HI. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. Lancet Oncol 2009; 10: 981-91.
    • (2009) Lancet Oncol , vol.10 , pp. 981-991
    • Chen, Y.1    Clegg, N.J.2    Scher, H.I.3
  • 9
    • 0027469525 scopus 로고
    • A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
    • Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993; 71: 1143-50. (Pubitemid 23049643)
    • (1993) Cancer , vol.71 , Issue.3 SUPPL. , pp. 1143-1150
    • Herr, H.W.1    Kornblith, A.B.2    Ofman, U.3
  • 10
    • 33750729609 scopus 로고    scopus 로고
    • Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review
    • DOI 10.1016/j.critrevonc.2006.06.006, PII S1040842806001144
    • Alibhai SM, Gogov S, Allibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 2006; 60: 201-15. (Pubitemid 44709617)
    • (2006) Critical Reviews in Oncology/Hematology , vol.60 , Issue.3 , pp. 201-215
    • Alibhai, S.M.H.1    Gogov, S.2    Allibhai, Z.3
  • 11
    • 64049106282 scopus 로고    scopus 로고
    • Metabolic complications of androgen deprivation therapy for prostate cancer
    • discussion, 2007-8
    • Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009; 181: 1998-2006; discussion 2007-8.
    • (2009) J Urol , vol.181 , pp. 1998-2006
    • Saylor, P.J.1    Smith, M.R.2
  • 12
    • 84857914524 scopus 로고    scopus 로고
    • Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure ormyocardial infarction
    • 25 June, doi:10.1016/j.ijrobp.2011.04.067
    • Nguyen PL, Chen MH, Beckman JA, Beard CJ,Martin NE et al. Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure ormyocardial infarction. Int J Radiat Oncol Biol Phys ; e-pub ahead of print 25 June 2011; doi:10.1016/j.ijrobp.2011.04.067.
    • (2011) Int J Radiat Oncol Biol Phys ; E-pub Ahead of Print
    • Nguyen, P.L.1    Chen, M.H.2    Beckman, J.A.3    Beard Cjmartin, N.E.4
  • 14
    • 0030876421 scopus 로고    scopus 로고
    • Quality of life in prostate cancer patients
    • Herr HW. Quality of life in prostate cancer patients. CA Cancer J Clin 1997; 47: 207-17. (Pubitemid 27375998)
    • (1997) Ca-A Cancer Journal for Clinicians , vol.47 , Issue.4 , pp. 207-217
    • Herr, H.W.1
  • 16
    • 32844466568 scopus 로고    scopus 로고
    • Complications of androgen-deprivation therapy in men with prostate cancer
    • Chen AC, Petrylak DP. Complications of androgen-deprivation therapy in men with prostate cancer. Curr Urol Rep 2005; 6: 210-6.
    • (2005) Curr Urol Rep , vol.6 , pp. 210-216
    • Chen, A.C.1    Petrylak, D.P.2
  • 17
    • 0032531859 scopus 로고    scopus 로고
    • The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: Longitudinal evaluation and response to intermittent cyclic etidronate therapy
    • DOI 10.1002/(SICI)1097-0142(19981015)83:8<1561::AID-CNCR11>3.0. CO;2-Z
    • Diamond T, Campbell J, Bryant C, Lynch W. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 1998; 83: 1561-6. (Pubitemid 28465474)
    • (1998) Cancer , vol.83 , Issue.8 , pp. 1561-1566
    • Diamond, T.1    Campbell, J.2    Bryant, C.3    Lynch, W.4
  • 19
    • 74049152290 scopus 로고    scopus 로고
    • Diabetes and cardiovascular disease during androgen deprivation therapy: Observational study of veterans with prostate cancer
    • Keating NL, O'Malley AJ, Freedland SJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst 2010; 102: 39-46.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 39-46
    • Keating, N.L.1    O'malley, A.J.2    Freedland, S.J.3    Smith, M.R.4
  • 20
    • 33644590549 scopus 로고    scopus 로고
    • Risk of the 'androgen deprivation syndrome' in men receiving androgen deprivation for prostate cancer
    • Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the 'androgen deprivation syndrome' in men receiving androgen deprivation for prostate cancer. Arch Intern Med 2006; 166: 465-71.
    • (2006) Arch Intern Med , vol.166 , pp. 465-471
    • Shahinian, V.B.1    Kuo, Y.F.2    Freeman, J.L.3    Goodwin, J.S.4
  • 21
    • 0028236854 scopus 로고
    • Quality of life of patients with prostate cancer and their spouses: The value of a data base in clinical care
    • DOI 10.1002/1097-0142(19940601)73:11<2791::AID-CNCR2820731123>3.0. CO;2-9
    • Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer 1994; 73: 2791-802. (Pubitemid 24166268)
    • (1994) Cancer , vol.73 , Issue.11 , pp. 2791-2802
    • Kornblith, A.B.1    Herr, H.W.2    Ofman, U.S.3    Scher, H.I.4    Holland, J.C.5
  • 22
    • 38549092220 scopus 로고    scopus 로고
    • Distress in couples coping with cancer: A meta-analysis and critical review of role and gender effects
    • Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC. Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull 2008; 134: 1-30.
    • (2008) Psychol Bull , vol.134 , pp. 1-30
    • Hagedoorn, M.1    Sanderman, R.2    Bolks, H.N.3    Tuinstra, J.4    Coyne, J.C.5
  • 23
    • 77956275686 scopus 로고    scopus 로고
    • Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life
    • Elliott S, Latini DM, Walker LM, Wassersug R, Robinson JW. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med 2010; 7: 2996-3010.
    • (2010) J Sex Med , vol.7 , pp. 2996-3010
    • Elliott, S.1    Latini, D.M.2    Walker, L.M.3    Wassersug, R.4    Robinson, J.W.5
  • 24
    • 67649216722 scopus 로고    scopus 로고
    • Body image perceptions in men with prostate cancer
    • Harrington JM, Jones EG, Badger T. Body image perceptions in men with prostate cancer. Oncol Nurs Forum 2009; 36: 167-72.
    • (2009) Oncol Nurs Forum , vol.36 , pp. 167-172
    • Harrington, J.M.1    Jones, E.G.2    Badger, T.3
  • 25
    • 68149124329 scopus 로고    scopus 로고
    • Body image and quality of life in men with prostate cancer
    • Harrington JM, Badger TA. Body image and quality of life in men with prostate cancer. Cancer Nurs 2009; 32: E1-7.
    • (2009) Cancer Nurs , vol.32
    • Harrington, J.M.1    Badger, T.A.2
  • 26
    • 63849142642 scopus 로고    scopus 로고
    • The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management
    • Wassersug RJ, Oliffe JL. The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management. J Sex Med 2009; 6: 989-1000.
    • (2009) J Sex Med , vol.6 , pp. 989-1000
    • Wassersug, R.J.1    Oliffe, J.L.2
  • 27
    • 1542780027 scopus 로고    scopus 로고
    • Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties
    • DOI 10.1177/1049732303258016
    • Navon L, Morag A. Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties. Qual Health Res 2003; 13: 1378-92. (Pubitemid 44526592)
    • (2003) Qualitative Health Research , vol.13 , Issue.10 , pp. 1378-1392
    • Navon, L.1    Morag, A.2
  • 28
    • 37349085284 scopus 로고    scopus 로고
    • Treatment of bicalutamide-induced breast events
    • DOI 10.1586/14737140.7.12.1773
    • Sieber PR. Treatment of bicalutamide-induced breast events. Expert Rev Anticancer Ther 2007; 7: 1773-9. (Pubitemid 350303007)
    • (2007) Expert Review of Anticancer Therapy , vol.7 , Issue.12 , pp. 1773-1779
    • Sieber, P.R.1
  • 30
    • 72149085457 scopus 로고    scopus 로고
    • An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients
    • Bedognetti D, Rubagotti A, Conti G, Francesca F, de Cobelli O et al. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Eur Urol 2010; 57: 238-45.
    • (2010) Eur Urol , vol.57 , pp. 238-245
    • Bedognetti, D.1    Rubagotti, A.2    Conti, G.3    Francesca, F.4    De Cobelli, O.5
  • 31
    • 59149095124 scopus 로고    scopus 로고
    • Mastering emasculation
    • Wassersug RJ. Mastering emasculation. J Clin Oncol 2009; 27: 634-6.
    • (2009) J Clin Oncol , vol.27 , pp. 634-636
    • Wassersug, R.J.1
  • 32
    • 0034805409 scopus 로고    scopus 로고
    • Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy
    • DOI 10.1016/S0090-4295(01)01270-5, PII S0090429501012705
    • Munding MD, Wessells HB, Dalkin BL. Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 2001; 58: 567-9. (Pubitemid 32904499)
    • (2001) Urology , vol.58 , Issue.4 , pp. 567-569
    • Munding, M.D.1    Wessells, H.B.2    Dalkin, B.L.3
  • 33
    • 33845296098 scopus 로고    scopus 로고
    • Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer
    • DOI 10.1016/j.juro.2006.08.113, PII S002253470602146X
    • Haliloglu A, Baltaci S, Yaman O. Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer. J Urol 2007; 177: 128-30. (Pubitemid 44879439)
    • (2007) Journal of Urology , vol.177 , Issue.1 , pp. 128-130
    • Haliloglu, A.1    Baltaci, S.2    Yaman, O.3
  • 34
    • 70649084289 scopus 로고    scopus 로고
    • Penile rehabilitation following radical prostatectomy: Predicting success
    • Muller A, Parker M, Waters BW, Flanigan RC, Mulhall JP. Penile rehabilitation following radical prostatectomy: predicting success. J Sex Med 2009; 6: 2806-12.
    • (2009) J Sex Med , vol.6 , pp. 2806-2812
    • Muller, A.1    Parker, M.2    Waters, B.W.3    Flanigan, R.C.4    Mulhall, J.P.5
  • 36
    • 27744579583 scopus 로고    scopus 로고
    • Sexual dysfunction after radical prostatectomy: Prevalence, treatments, restricted use of treatments and distress
    • DOI 10.1097/01.ju.0000181206.16447.e2
    • Matthew AG, Goldman A, Trachtenberg J, Robinson J, Horsburgh S et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol 2005; 174: 2105-10. (Pubitemid 41611746)
    • (2005) Journal of Urology , vol.174 , Issue.6 , pp. 2105-2110
    • Matthew, A.G.1    Goldman, A.2    Trachtenberg, J.3    Robinson, J.4    Horsburgh, S.5    Currie, K.6    Ritvo, P.7
  • 37
    • 70649091380 scopus 로고    scopus 로고
    • Erectile dysfunction (ED) is a shared sexual concern of couples I: Couple conceptions of ED
    • Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med 2009; 6: 2746-60.
    • (2009) J Sex Med , vol.6 , pp. 2746-2760
    • Fisher, W.A.1    Eardley, I.2    McCabe, M.3    Sand, M.4
  • 38
    • 70649104819 scopus 로고    scopus 로고
    • Erectile dysfunction (ED) is a shared sexual concern of couples II: Association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization
    • Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization. J Sex Med 2009; 6: 3111-24.
    • (2009) J Sex Med , vol.6 , pp. 3111-3124
    • Fisher, W.A.1    Eardley, I.2    McCabe, M.3    Sand, M.4
  • 39
    • 0034799317 scopus 로고    scopus 로고
    • Sexuality after treatment for early prostate cancer: Exploring the meanings of "Erectile Dysfunction"
    • DOI 10.1046/j.1525-1497.2001.00832.x
    • Bokhour BG, Clark JA, Inui TS, Silliman RA, Talcott JA. Sexuality after treatment for early prostate cancer: exploring the meanings of "erectile dysfunction". J Gen Intern Med 2001; 16: 649-55. (Pubitemid 32964844)
    • (2001) Journal of General Internal Medicine , vol.16 , Issue.10 , pp. 649-655
    • Bokhour, B.G.1    Clark, J.A.2    Inui, T.S.3    Silliman, R.A.4    Talcott, J.A.5
  • 40
    • 34548283574 scopus 로고    scopus 로고
    • No less a man: Reconstructing identity after prostate cancer
    • DOI 10.1515/CAM.2007.010
    • Bokhour BG, Powel LL, Clark JA. No less a man: reconstructing identity after prostate cancer. Commun Med 2007; 4: 99-109. (Pubitemid 47324914)
    • (2007) Communication and Medicine , vol.4 , Issue.1 , pp. 99-109
    • Bokhour, B.G.1    Powel, L.L.2    Clark, J.A.3
  • 41
    • 1242274342 scopus 로고    scopus 로고
    • Sexual functioning and quality of life after prostate cancer treatment: Considering sexual desire
    • DOI 10.1016/j.urology.2003.09.048
    • Dahn JR, Penedo FJ, Gonzalez JS, Esquiabro M, Antoni MH et al. Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology 2004; 63: 273-7. (Pubitemid 38234417)
    • (2004) Urology , vol.63 , Issue.2 , pp. 273-277
    • Dahn, J.R.1    Penedo, F.J.2    Gonzalez, J.S.3    Esquiabro, M.4    Antoni, M.H.5    Roos, B.A.6    Schneiderman, N.7
  • 42
    • 33749475980 scopus 로고    scopus 로고
    • How do men perceive erectile dysfunction and its treatment? A qualitative study on opinions of men
    • Low WY, Ng CJ, Choo WY, Tan HM. How do men perceive erectile dysfunction and its treatment? A qualitative study on opinions of men. Aging Male 2006; 9: 175-80.
    • (2006) Aging Male , vol.9 , pp. 175-180
    • Low, W.Y.1    Ng, C.J.2    Choo, W.Y.3    Tan, H.M.4
  • 43
    • 46649104467 scopus 로고    scopus 로고
    • Sexual functioning as a moderator of the relationship between masculinity and men's adjustment following treatment for prostate cancer
    • Burns SM, Mahalik JR. Sexual functioning as a moderator of the relationship between masculinity and men's adjustment following treatment for prostate cancer.AmJ Mens Health 2008; 2: 6-16.
    • (2008) AmJ Mens Health , vol.2 , pp. 6-16
    • Burns, S.M.1    Mahalik, J.R.2
  • 44
    • 33750488418 scopus 로고    scopus 로고
    • Longitudinal differences in psychological outcomes for Men with erectile dysfunction: Results from ExCEED™
    • DOI 10.1111/j.1743-6109.2006.00332.x
    • Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED. J Sex Med 2006; 3: 1068-76. (Pubitemid 44644719)
    • (2006) Journal of Sexual Medicine , vol.3 , Issue.6 , pp. 1068-1076
    • Latini, D.M.1    Penson, D.F.2    Wallace, K.L.3    Lubeck, D.P.4    Lue, T.F.5
  • 45
    • 33750441822 scopus 로고    scopus 로고
    • Clinical and psychosocial characteristics of men with erectile dysfunction: Baseline data from ExCEED™
    • DOI 10.1111/j.1743-6109.2006.00331.x
    • Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED. J Sex Med 2006; 3: 1059-67. (Pubitemid 44644718)
    • (2006) Journal of Sexual Medicine , vol.3 , Issue.6 , pp. 1059-1067
    • Latini, D.M.1    Penson, D.F.2    Wallace, K.L.3    Lubeck, D.P.4    Lue, T.F.5
  • 46
    • 4644242940 scopus 로고    scopus 로고
    • The assessment of sexual functions in women with male partners complaining of erectile dysfunction: Does treatment of male sexual dysfunction improve female partner's sexual functions?
    • DOI 10.1080/00926230490465091
    • Cayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner's sexual functions? J Sex Marital Ther 2004; 30: 333-41. (Pubitemid 39304860)
    • (2004) Journal of Sex and Marital Therapy , vol.30 , Issue.5 , pp. 333-341
    • Cayan, S.1    Bozlu, M.2    Canpolat, B.3    Akbay, E.4
  • 47
    • 72949085547 scopus 로고    scopus 로고
    • Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
    • Jockenhovel F, Minnemann T, Schubert M, Freude S, Hubler D et al. Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood. Aging Male 2009; 12: 113-8.
    • (2009) Aging Male , vol.12 , pp. 113-118
    • Jockenhovel, F.1    Minnemann, T.2    Schubert, M.3    Freude, S.4    Hubler, D.5
  • 48
    • 28444486296 scopus 로고    scopus 로고
    • The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function
    • DOI 10.1111/j.1743-6109.2005.00094.x
    • Traish A, Kim N. The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med 2005; 2: 759-70. (Pubitemid 41727389)
    • (2005) Journal of Sexual Medicine , vol.2 , Issue.6 , pp. 759-770
    • Traish, A.1    Kim, N.2
  • 49
    • 68549087113 scopus 로고    scopus 로고
    • Androgens play a pivotal role in maintaining penile tissue architecture and erection: A review
    • Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review. J Androl 2009; 30: 363-9.
    • (2009) J Androl , vol.30 , pp. 363-369
    • Traish, A.M.1
  • 50
    • 33745253926 scopus 로고    scopus 로고
    • Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: A series of case reports
    • Yassin AA, Saad F, Traish A. Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports. J Sex Med 2006; 3: 727-35.
    • (2006) J Sex Med , vol.3 , pp. 727-735
    • Yassin, A.A.1    Saad, F.2    Traish, A.3
  • 51
    • 79955851972 scopus 로고    scopus 로고
    • Use of testosterone replacement therapy in patients with prostate cancer
    • Dorff TB, Vogelzang NJ. Use of testosterone replacement therapy in patients with prostate cancer. Curr Urol Rep 2011; 12: 223-8.
    • (2011) Curr Urol Rep , vol.12 , pp. 223-228
    • Dorff, T.B.1    Vogelzang, N.J.2
  • 53
    • 78651322584 scopus 로고    scopus 로고
    • Premature and delayed ejaculation: Two ends of a single continuum influenced by hormonal milieu
    • Corona G, Jannini EA, Lotti F, Boddi V, de Vita G et al. Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu. Int J Androl 2011; 34: 41-8.
    • (2011) Int J Androl , vol.34 , pp. 41-48
    • Corona, G.1    Jannini, E.A.2    Lotti, F.3    Boddi, V.4    De Vita, G.5
  • 54
    • 0032402165 scopus 로고    scopus 로고
    • Penile sensitivity in men: A composite of recent findings
    • DOI 10.1016/S0090-4295(98)00413-0, PII S0090429598004130
    • Rowland DL. Penile sensitivity in men: a composite of recent findings. Urology 1998; 52: 1101-5. (Pubitemid 28533385)
    • (1998) Urology , vol.52 , Issue.6 , pp. 1101-1105
    • Rowland, D.L.1
  • 55
    • 34248191739 scopus 로고    scopus 로고
    • Orgasm Associated Incontinence (Climacturia) Following Radical Pelvic Surgery: Rates of Occurrence and Predictors
    • DOI 10.1016/j.juro.2007.01.150, PII S0022534707002881
    • Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol 2007; 177: 2223-6. (Pubitemid 46726416)
    • (2007) Journal of Urology , vol.177 , Issue.6 , pp. 2223-2226
    • Choi, J.M.1    Nelson, C.J.2    Stasi, J.3    Mulhall, J.P.4
  • 56
    • 7444253855 scopus 로고    scopus 로고
    • Restoring sexual function in prostate cancer patients: An innovative approach
    • Gray RE, Klotz LH. Restoring sexual function in prostate cancer patients: an innovative approach. Can J Urol 2004; 11: 2285-9.
    • (2004) Can J Urol , vol.11 , pp. 2285-2289
    • Gray, R.E.1    Klotz, L.H.2
  • 57
    • 80052943921 scopus 로고    scopus 로고
    • Impact of androgen deprivation on physical well-being in patients with prostate cancer: Analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry
    • Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR et al. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer 2011; 117: 4406-13.
    • (2011) Cancer , vol.117 , pp. 4406-4413
    • Sadetsky, N.1    Greene, K.2    Cooperberg, M.R.3    Hubbard, A.4    Carroll, P.R.5
  • 58
    • 33645113009 scopus 로고    scopus 로고
    • Quality of life in prostate cancer patients taking androgen deprivation therapy
    • Dacal K, Sereika SM, Greenspan SL. Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc 2006; 54: 85-90.
    • (2006) J Am Geriatr Soc , vol.54 , pp. 85-90
    • Dacal, K.1    Sereika, S.M.2    Greenspan, S.L.3
  • 59
    • 68049130065 scopus 로고    scopus 로고
    • A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
    • Newton RU, Taaffe DR, Spry N, Gardiner RA, Levin G et al. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer 2009; 9: 210.
    • (2009) BMC Cancer , vol.9 , pp. 210
    • Newton, R.U.1    Taaffe, D.R.2    Spry, N.3    Gardiner, R.A.4    Levin, G.5
  • 60
    • 84855284565 scopus 로고    scopus 로고
    • Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: A systematic review
    • 1 Jun, doi:10.1016/j.jpainsymman.2011.03.006
    • Keogh JW, Macleod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manage; e-pub ahead of print 1 Jun 2011; doi:10.1016/j.jpainsymman.2011.03.006.
    • (2011) J Pain Symptom Manage; E-pub Ahead of Print
    • Keogh, J.W.1    MacLeod, R.D.2
  • 62
    • 79955751754 scopus 로고    scopus 로고
    • Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: A feasibility study
    • Bourke L, Doll H, Crank H, Daley A, Rosario D et al. Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev 2011; 20: 647-57.
    • (2011) Cancer Epidemiol Biomarkers Prev , vol.20 , pp. 647-657
    • Bourke, L.1    Doll, H.2    Crank, H.3    Daley, A.4    Rosario, D.5
  • 63
    • 79958113565 scopus 로고    scopus 로고
    • Efficacy of a referral and physical activity program for survivors of prostate cancer [ENGAGE]: Rationale and design for a cluster randomised controlled trial
    • Livingston PM, Salmon J, Courneya KS, Gaskin CJ, CraikeMet al. Efficacy of a referral and physical activity program for survivors of prostate cancer [ENGAGE]: rationale and design for a cluster randomised controlled trial. BMC Cancer 2011; 11: 237.
    • (2011) BMC Cancer , vol.11 , pp. 237
    • Livingston, P.M.1    Salmon, J.2    Courneya, K.S.3    Gaskin, C.J.4    Craike, M.5
  • 64
    • 17444418615 scopus 로고    scopus 로고
    • Sexual, psychological and dyadic qualities of the prostate cancer 'couple'
    • DOI 10.1111/j.1464-410X.2005.05400.x
    • Soloway CT, Soloway MS, Kim SS, Kava BR. Sexual, psychological and dyadic qualities of the prostate cancer 'couple'. BJU Int 2005; 95: 780-5. (Pubitemid 40547206)
    • (2005) BJU International , vol.95 , Issue.6 , pp. 780-785
    • Soloway, C.T.1    Soloway, M.S.2    Kim, S.S.3    Kava, B.R.4
  • 65
    • 0033762394 scopus 로고    scopus 로고
    • Psychosocial morbidity in prostate cancer: II A comparison of patients and partners
    • Cliff AM, MacDonagh RP. Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 2000; 86: 834-9.
    • (2000) BJU Int , vol.86 , pp. 834-839
    • Cliff, A.M.1    MacDonagh, R.P.2
  • 68
    • 0038548271 scopus 로고    scopus 로고
    • Advanced prostate cancer patients' relationships with their spouses following hormonal therapy
    • DOI 10.1016/S1462-3889(03)00022-X
    • Navon L, Morag A. Advanced prostate cancer patients' relationships with their spouses following hormonal therapy. Eur J Oncol Nurs 2003; : 73-80; discussion 81-2. (Pubitemid 36747877)
    • (2003) European Journal of Oncology Nursing , vol.7 , Issue.2 , pp. 73-80
    • Navon, L.1    Morag, A.2
  • 69
    • 77249164733 scopus 로고    scopus 로고
    • The unique needs of couples experiencing androgen deprivation therapy for prostate cancer
    • Walker LM, Robinson JW. The unique needs of couples experiencing androgen deprivation therapy for prostate cancer. J Sex Marital Ther 2010; 36: 154-65.
    • (2010) J Sex Marital Ther , vol.36 , pp. 154-165
    • Walker, L.M.1    Robinson, J.W.2
  • 70
    • 79952426370 scopus 로고    scopus 로고
    • Androgen deprivation therapy for prostate cancer: Not so simple
    • Tadros NN, Garzotto M. Androgen deprivation therapy for prostate cancer: not so simple. Asian J Androl 2011; 13: 187-8.
    • (2011) Asian J Androl , vol.13 , pp. 187-188
    • Tadros, N.N.1    Garzotto, M.2
  • 71
    • 33746076017 scopus 로고    scopus 로고
    • Hormone ablation for the treatment of prostate cancer: The lived experience
    • discussion, 215-8
    • Ng C, Kristjanson LJ, Medigovich K. Hormone ablation for the treatment of prostate cancer: the lived experience. Urol Nurs 2006; 26: 204-12; discussion 215-8.
    • (2006) Urol Nurs , vol.26 , pp. 204-212
    • Ng, C.1    Kristjanson, L.J.2    Medigovich, K.3
  • 72
    • 79951896163 scopus 로고    scopus 로고
    • Impact of androgendeprivation therapy on cognitive function in men with nonmetastatic prostate cancer
    • Alibhai SM, Breunis H, Timilshina N, Marzouk S, Stewart D et al. Impact of androgendeprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 2010; 28: 5030-7.
    • (2010) J Clin Oncol , vol.28 , pp. 5030-5037
    • Alibhai, S.M.1    Breunis, H.2    Timilshina, N.3    Marzouk, S.4    Stewart, D.5
  • 73
    • 52049122207 scopus 로고    scopus 로고
    • Cognitive effects of hormone therapy in men with prostate cancer: A review
    • Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer 2008; 113: 1097-106.
    • (2008) Cancer , vol.113 , pp. 1097-1106
    • Nelson, C.J.1    Lee, J.S.2    Gamboa, M.C.3    Roth, A.J.4
  • 74
    • 33750505645 scopus 로고    scopus 로고
    • Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer
    • DOI 10.1016/j.juro.2006.07.151, PII S002253470601932X
    • Joly F, Alibhai SM, Galica J, Park A, Yi QL et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 2006; 176: 2443-7. (Pubitemid 44665959)
    • (2006) Journal of Urology , vol.176 , Issue.6 , pp. 2443-2447
    • Joly, F.1    Alibhai, S.M.H.2    Galica, J.3    Park, A.4    Yi, Q.-L.5    Wagner, L.6    Tannock, I.F.7
  • 75
    • 2342626087 scopus 로고    scopus 로고
    • Complications of androgen deprivation therapy for prostate cancer
    • DOI 10.1097/00042307-200405000-00007
    • Holzbeierlein JM, McLaughlin MD, Thrasher JB. Complications of androgen deprivation therapy for prostate cancer. Curr Opin Urol 2004; 14: 177-83. (Pubitemid 38582317)
    • (2004) Current Opinion in Urology , vol.14 , Issue.3 , pp. 177-183
    • Holzbeierlein, J.M.1    McLaughlin, M.D.2    Thrasher, J.B.3
  • 76
    • 0034114889 scopus 로고    scopus 로고
    • Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy
    • Herr HW, O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol 2000; 163: 1743-6. (Pubitemid 30366726)
    • (2000) Journal of Urology , vol.163 , Issue.6 , pp. 1743-1746
    • Herr, H.W.1    O'Sullivan, M.2
  • 77
    • 67349254217 scopus 로고    scopus 로고
    • Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer
    • Cherrier MM, Aubin S, Higano CS. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology 2009; 18: 237-47.
    • (2009) Psychooncology , vol.18 , pp. 237-247
    • Cherrier, M.M.1    Aubin, S.2    Higano, C.S.3
  • 78
    • 70349561237 scopus 로고    scopus 로고
    • Update on the state of the science: Sleep-wake disturbances in adult patients with cancer
    • Berger AM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum 2009; 36: E165-77.
    • (2009) Oncol Nurs Forum , vol.36
    • Berger, A.M.1
  • 81
    • 28344440093 scopus 로고    scopus 로고
    • Psychological functioning associated with prostate cancer: Cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery
    • DOI 10.1016/j.jpainsymman.2005.05.011, PII S0885392405004768
    • Hervouet S, Savard J, Simard S, Ivers H, Laverdiere J et al. Psychological functioning associated with prostate cancer: cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. J Pain Symptom Manage 2005; 30: 474-84. (Pubitemid 41718967)
    • (2005) Journal of Pain and Symptom Management , vol.30 , Issue.5 , pp. 474-484
    • Hervouet, S.1    Savard, J.2    Simard, S.3    Ivers, H.4    Laverdiere, J.5    Vigneault, E.6    Fradet, Y.7    Lacombe, L.8
  • 82
    • 0027416692 scopus 로고
    • Effects of intermittent androgen suppression on androgen-dependent tumors: Apoptosis and serum prostate-specific antigen
    • Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR et al. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 1993; 71: 2782-90. (Pubitemid 23120055)
    • (1993) Cancer , vol.71 , Issue.9 , pp. 2782-2790
    • Akakura, K.1    Bruchovsky, N.2    Goldenberg, S.L.3    Rennie, P.S.4    Buckley, A.R.5    Sullivan, L.D.6
  • 84
    • 0034903581 scopus 로고    scopus 로고
    • Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy
    • DOI 10.1016/S0090-4295(01)01243-2, PII S0090429501012432
    • Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM et al. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy. Urology 2001; 58: 56-64. (Pubitemid 32743411)
    • (2001) Urology , vol.58 , Issue.2 SUPPL. 1 , pp. 56-64
    • Grossfeld, G.D.1    Small, E.J.2    Lubeck, D.P.3    Latini, D.4    Broering, J.M.5    Carroll, P.R.6
  • 85
    • 84858060402 scopus 로고    scopus 로고
    • Dynamics of bone mineral density during intermittent androgen deprivation for men with biochemical recurrence of prostate cancer
    • abstr 4558
    • Yu EY, Kuo K, Gulati R, Jiang PY, Higano CS. Dynamics of bone mineral density during intermittent androgen deprivation for men with biochemical recurrence of prostate cancer. J Clin Oncol 2010; 28: abstr 4558.
    • (2010) J Clin Oncol , vol.28
    • Yu, E.Y.1    Kuo, K.2    Gulati, R.3    Jiang, P.Y.4    Higano, C.S.5
  • 86
    • 84858049027 scopus 로고    scopus 로고
    • A phase III randomized trial of intermittent vs. continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013)
    • abstr 4514
    • Crook JM, O'Callaghan CJ, Ding K, Duncan G, Dearnaley DP et al. A phase III randomized trial of intermittent vs. continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013). J Clin Oncol 2011; 29: abstr 4514.
    • (2011) J Clin Oncol , vol.29
    • Crook, J.M.1    O'callaghan, C.J.2    Ding, K.3    Duncan, G.4    Dearnaley, D.P.5
  • 87
    • 65049090443 scopus 로고    scopus 로고
    • Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: Results from a randomised phase 3 study of the South European Uroncological Group
    • Calais da Silva FE, Bono AV, Whelan P, Brausi M, Marques Queimadelos A et al. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group. Eur Urol 2009; 55: 1269-77.
    • (2009) Eur Urol , vol.55 , pp. 1269-1277
    • Calais Da Silva, F.E.1    Bono, A.V.2    Whelan, P.3    Brausi, M.4    Marques, Q.A.5
  • 88
    • 84858060408 scopus 로고    scopus 로고
    • QOL/outcomes of an international phase 3 trial of intermittent vs continuous hormone therapy for relapsed prostate
    • May London, UK 2011, 15
    • Duncan GG, O'Callaghan CJ, Ding K, Dearnaley DP, Higano CS. QOL/outcomes of an international phase 3 trial of intermittent vs continuous hormone therapy for relapsed prostate. In: Proceedings of the ESTRO Anniversary Congress, 2011 May 8-12; London, UK; 2011. p15.
    • (2011) Proceedings of the ESTRO Anniversary Congress , pp. 8-12
    • Duncan, G.G.1    O'callaghan, C.J.2    Ding, K.3    Dearnaley, D.P.4    Higano, C.S.5
  • 89
    • 75249099667 scopus 로고    scopus 로고
    • Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
    • Irani J, Salomon L, Oba R, Bouchard P, Mottet N. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 2010; 11: 147-54.
    • (2010) Lancet Oncol , vol.11 , pp. 147-154
    • Irani, J.1    Salomon, L.2    Oba, R.3    Bouchard, P.4    Mottet, N.5
  • 90
    • 70349996465 scopus 로고    scopus 로고
    • Hormone therapy and cognitive function
    • Maki PM, Sundermann E. Hormone therapy and cognitive function. Hum Reprod Update 2009; 15: 667-81.
    • (2009) Hum Reprod Update , vol.15 , pp. 667-681
    • Maki, P.M.1    Sundermann, E.2
  • 91
    • 65149097788 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitor-induced sexual dysfunction
    • Corona G, Ricca V, Bandini E, Mannucci E, Lotti F et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med 2009; 6: 1259-69.
    • (2009) J Sex Med , vol.6 , pp. 1259-1269
    • Corona, G.1    Ricca, V.2    Bandini, E.3    Mannucci, E.4    Lotti, F.5
  • 92
    • 42249110691 scopus 로고    scopus 로고
    • Quality of life of couples dealing with cancer: Dyadic and individual adjustment among breast and prostate cancer survivors and their spousal caregivers
    • Kim Y, Kashy DA, Wellisch DK, Spillers RL, Kaw CK et al. Quality of life of couples dealing with cancer: dyadic and individual adjustment among breast and prostate cancer survivors and their spousal caregivers. Ann Behav Med 2008; 35: 230-8.
    • (2008) Ann Behav Med , vol.35 , pp. 230-238
    • Kim, Y.1    Kashy, D.A.2    Wellisch, D.K.3    Spillers, R.L.4    Kaw, C.K.5
  • 93
    • 72049107165 scopus 로고    scopus 로고
    • A holistic approach to androgen deprivation therapy: Treating the cancer without hurting the patient
    • Tombal B. A holistic approach to androgen deprivation therapy: treating the cancer without hurting the patient. Urol Int 2009; 83: 373-8.
    • (2009) Urol Int , vol.83 , pp. 373-378
    • Tombal, B.1
  • 94
    • 84858060407 scopus 로고    scopus 로고
    • Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life
    • Science Press Inc.
    • Wassersug R. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. Uro Today Berkeley, CA, Digital Science Press Inc.; 2010.
    • (2010) Uro Today Berkeley CA Digital
    • Wassersug, R.1
  • 95
    • 56649116179 scopus 로고    scopus 로고
    • The efficacy and safety of degarelix: A 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
    • Klotz L, Boccon-Gibod L, Shore ND, Andreou C, Persson BE et al. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer. BJU Int 2008; 102: 1531-8.
    • (2008) BJU Int , vol.102 , pp. 1531-1538
    • Klotz, L.1    Boccon-Gibod, L.2    Shore, N.D.3    Andreou, C.4    Persson, B.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.